Deep Track Biotechnology Fund, LP
Deep Track Biotechnology Fund, LP is a hedge fund based in Greenwich, Connecticut. According to its most recent Form D, filed Apr 1, 2026, the fund has sold $842,046,233 of interests to 44 investors since its first sale in Apr 2021. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Nir Messafi; David Kroin; Deep Track Biotechnology Fund GP, LLC.
Performance
No verified returns have been reported for this fund. As a rough guide, Deep Track Capital, LP, which manages it, disclosed U.S. stock holdings that returned an estimated +24.3% 2026 YTD through Jun 30 (S&P 500: +9.5%), based only on its public 13F filings. Over a longer period, Q3 2024 to Q2 2026, the estimate is +98.5% (S&P 500: +37.2%).
This estimate covers the firm's whole disclosed long U.S. stock portfolio. It is not this fund's return and excludes dividends, fees, shorts, derivatives, bonds, cash and trading within each quarter.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $842,046,233Cumulative sales reported on Form D
- Investors
- 44
- First sale
- Apr 1, 2021
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Nir Messafi; David Kroin; Deep Track Biotechnology Fund GP, LLC
- Latest Form D
- Apr 1, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Deep Track Biotechnology Fund, LP
What is the minimum investment for Deep Track Biotechnology Fund, LP?
Deep Track Biotechnology Fund, LP's latest Form D, filed Apr 1, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Deep Track Biotechnology Fund, LP?
Deep Track Biotechnology Fund, LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Deep Track Biotechnology Fund, LP raised?
Deep Track Biotechnology Fund, LP reports $842,046,233 sold from 44 investors on its Form D filed Apr 1, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is Deep Track Biotechnology Fund, LP based?
Deep Track Biotechnology Fund, LP is based in Greenwich, Connecticut and is managed by Deep Track Capital, LP.
When did Deep Track Biotechnology Fund, LP launch?
Deep Track Biotechnology Fund, LP reports its first sale in Apr 2021.
Size compared with every hedge fund
Raised more than 92% of the 862 hedge funds based in Connecticut, and more than 88% of all 10,307 that report sales.